<html>
<head>PUBMED IDs for DCR2</head>
<body bgcolor='#C5F0F2'><h1>DCR2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14506696/'>Clustering of hypermethylated genes in neuroblastoma.</a> September 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15788647/'>Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.</a> March 25  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16044164/'>Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.</a> July 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16675956/'>Regulation of alphaA-crystallin via Pax6, c-Maf, CREB and a broad domain of lens-specific chromatin.</a> May 6  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17545522/'>Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.</a> June 5  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310272/'>The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310270/'>&quot;SCA16&quot; is really SCA15.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310267/'>Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310265/'>A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310264/'>Heterogeneity in the processing defect of SLC26A4 mutants.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310263/'>Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients: a large scale mutation screening study.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18980997/'>Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma.</a> November 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19002696/'>Carbon dioxide does not affect the methylation status of prognostic important oncogenes Rassf1A and DCR2 in neuroblastoma cells.</a> November 13  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22159596/'>Association of aberrant DNA methylation with clinicopathological features in breast cancer.</a> July 24  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23154831/'>Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24573469/'>Epigenetic alterations in sporadic basal cell carcinomas.</a> April 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24680815/'>RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients.</a> July 11  2014<br></body></html>
